The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth

Nature

Volumn 456, Issue 7218, 2008, Pages 112-115

  Huang, Jin ^a   Lesser, Cammie F ^a   Lory, Stephen ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; COPN PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

BACTERIUM; GENE EXPRESSION; GROWTH RATE; IDENTIFICATION METHOD; INHIBITION; LEAD; MAMMAL; MEDICINE; PATHOGENICITY; PROTEIN; VIRULENCE; YEAST;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL CYCLE ARREST; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOSKELETON; GROWTH INHIBITION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MAMMAL CELL; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; YEAST CELL;

ANIMALS; BACTERIAL PROTEINS; CELL CYCLE; CELL LINE; CHLAMYDOPHILA PNEUMONIAE; GENE EXPRESSION; GENES, ESSENTIAL; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; INTRACELLULAR SPACE; MICROTUBULES; SACCHAROMYCES CEREVISIAE; VIRULENCE; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; MAMMALIA;

EID: 55549138715     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature07355     Document Type: Article

References (38)

1. Falkow, S. Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10 (Suppl. 2), S274-S276 (1988).
2. Campbell, L. A. & Kuo, C. C. Chlamydia pneumoniae -an infectious risk factor for atherosclerosis? Nature Rev. Microbiol. 2, 23-32 (2004).
3. Hackstadt, T. in Chlamydia: Intracellular Biology, Pathogenesis, and Immunity (ed. Stephens, R. S.) 101-138 (ASM Press, 1999).
4. Crocker, T. T., Pelc, S. R., Nielsen, B. I., Eastwood, J. M. & Banks, J. Population dynamics and deoxyribonucleic acid synthesis in HeLa cells infected with an ornithosis agent. J. Infect. Dis. 115, 105-122 (1965).
5. Hackstadt, T., Scidmore, M. A. & Rockey, D. D. Lipid metabolism in Chlamydia trachomatis-infected cells: Directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc. Natl Acad. Sci. USA 92, 4877-4881 (1995).
6. Fan, T. et al. Inhibition of apoptosis in Chlamydia-infected cells: Blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187, 487-496 (1998).
7. Carabeo, R. A., Grieshaber, S. S., Fischer, E. & Hackstadt, T. Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect. Immun. 70, 3793-3803 (2002).
8. Carabeo, R. A., Mead, D. J. & Hackstadt, T. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc. Natl Acad. Sci. USA 100, 6771-6776 (2003).
9. Su, H. et al. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 279, 9409-9416 (2004).
10. Hsia, R. C., Pannekoek, Y., Ingerowski, E. & Bavoil, P. M. Type III secretion genes identify a putative virulence locus of Chlamydia. Mol. Microbiol. 25, 351-359 (1997).
11. Fields, K. A., Mead, D. J., Dooley, C. A. & Hackstadt, T. Chlamydia trachomatis type III secretion: Evidence for a functional apparatus during early-cycle development. Mol. Microbiol. 48, 671-683 (2003).
12. Peters, J., Wilson, D. P., Myers, G., Timms, P. & Bavoil, P. M. Type III secretion a la Chlamydia. Trends Microbiol. 15, 241-251 (2007).
13. Valdivia, R. H. Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Curr. Opin. Microbiol. 11, 53-59 (2008).
14. Lesser, C. F.&Miller, S. I. Expression ofmicrobial virulence proteins in Saccharomyces cerevisiae models mammalian infection. EMBO J. 20, 1840-1849 (2001).
15. Siggers, K. A. & Lesser, C. F. The yeast Saccharomyces cerevisiae: A versatile model system for the identification and characterization of bacterial virulence proteins. Cell Host Microbe 4, 8-15 (2008).
16. Lugert, R., Kuhns, M., Polch, T. & Gross, U. Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae. Med. Microbiol. Immunol. (Berl.) 193, 163-171 (2004).
17. Verma, A. & Maurelli, A. T. Identification of two eukaryote-like serine/threonine kinases encoded by Chlamydia trachomatis serovar L2 and characterization of interacting partners of Pkn1. Infect. Immun. 71, 5772-5784 (2003).
18. Li, D. et al. High-yield culture and purification of Chlamydiaceae bacteria. J. Microbiol. Methods 61, 17-24 (2005).
19. Khan, M. A., Potter, C. W. & Sharrard, R. M. A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae. J. Antimicrob. Chemother. 37, 677-685 (1996).
20. Cross, N. A. et al. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method. Antimicrob. Agents Chemother. 43, 2311-2313 (1999).
21. Huang, J. et al. The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease. Proc. Natl Acad. Sci. USA 99, 3914-3919 (2002).
22. Moulder, J. W. The relation of basic biology to pathogenic potential in the genus Chlamydia. Infection 10 (Suppl 1), S10-S18 (1982).
23. Sisko, J. L., Spaeth, K., Kumar, Y. & Valdivia, R. H. Multifunctional analysis of Chlamydia-specific genes in a yeast expression system. Mol. Microbiol. 60, 51-66 (2006).
24. Horoschak, K. D. & Moulder, J. W. Division of single host cells after infection with chlamydiae. Infect. Immun. 19, 281-286 (1978).
25. Oswald, E., Nougayrede, J. P., Taieb, F. & Sugai, M. Bacterial toxins that modulate host cell-cycle progression. Curr. Opin. Microbiol. 8, 83-91 (2005).
26. Shafikhani, S. H. & Engel, J. Pseudomonas aeruginosa type III-secreted toxin ExoT inhibits host-cell division by targeting cytokinesis at multiple steps. Proc. Natl Acad. Sci. USA 103, 15605-15610 (2006).
27. Lee, V. T., Anderson, D. M. & Schneewind, O. Targeting of Yersinia Yop proteins into the cytosol of HeLa cells: One-step translocation of YopE across bacterial and eukaryotic membranes is dependent on SycE chaperone. Mol. Microbiol. 28, 593-601 (1998).
28. Day, J. B., Ferracci, F. & Plano, G. V. Translocation of YopE and YopN into eukaryotic cells by Yersinia pestis yopN, tyeA, sycN, yscB and lcrG deletion mutants measured using a phosphorylatable peptide tag and phosphospecific antibodies. Mol. Microbiol. 47, 807-823 (2003).
29. Chen, Y., Smith, M. R., Thirumalai, K. & Zychlinsky, A. A bacterial invasin induces macrophage apoptosis by binding directly to ICE. EMBO J. 15, 3853-3860 (1996).
30. Guichon, A., Hersh, D., Smith, M. R.&Zychlinsky, A. Structure-function analysis of the Shigella virulence factor IpaB. J. Bacteriol. 183, 1269-1276 (2001).
31. Mumberg, D., Muller, R. & Funk, M. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 156, 119-122 (1995).
32. Gietz, R. D. & Woods, R. A. Transformation of yeast by lithium acetate/singlestranded carrier DNA/polyethylene glycol method. Methods Enzymol. 350, 87-96 (2002).
33. Miller, R. K. Monitoring spindle assembly and disassembly in yeast by indirect immunofluorescence. Methods Mol. Biol. 241, 341-352 (2004).
34. Day, A., Schneider, C. & Schneider, B. L. Yeast cell synchronization. Methods Mol. Biol. 241, 55-76 (2004).
35. Zhang, H. & Siede, W. Analysis of the budding yeast Saccharomyces cerevisiae cell cycle by morphological criteria and flow cytometry. Methods Mol. Biol. 241, 77-91 (2004).
36. Dorer, R. K. et al. A small-molecule inhibitor of Mps1 blocks the spindlecheckpoint response to a lack of tension on mitotic chromosomes. Curr. Biol. 15, 1070-1076 (2005).
37. Tugendreich, S. et al. A streamlined process to phenotypically profile heterologous cDNAs in parallel using yeast cell-based assays. Genome Res. 11, 1899-1912 (2001).
38. Perkins, E. et al. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res. 61, 4175-4183 (2001).